Invasive pulmonary aspergillosis among patients with severe community-acquired pneumonia and influenza in ICUs: a retrospective cohort study.

Wei-Chun LeeChe-Chia ChangMeng-Chin HoChieh-Mo LinShaw-Woei LeuChin-Kuo LinYu-Hung FangShu-Yi HuangYu-Ching LinMin-Chun ChuangTsung-Ming YangMing-Szu HungYen-Li ChouYing-Huang TsaiMeng-Jer Hsieh

Published in: Pneumonia (Nathan Qld.) (2024)

An aggressive diagnostic approach for IPA patients with severe CAP and not only influenza or COVID-19 should be pursued. Further randomized controlled trials need to evaluate the timing, safety, and efficacy of antifungal therapy in reducing IPA incidence and improving clinical outcomes.

Keyphrases

community acquired pneumonia
randomized controlled trial
coronavirus disease
early onset
sars cov
pulmonary hypertension
risk factors
drug induced
clinical trial
systematic review